IMPROVED PROGNOSIS OF DIFFUSE HISTIOCYTIC AND UNDIFFERENTIATED LYMPHOMA BY USE OF HIGH-DOSE METHOTREXATE ALTERNATING WITH STANDARD AGENTS (M-BACOD)

被引：360

作者：

SKARIN, AT

CANELLOS, GP

ROSENTHAL, DS

CASE, DC

MACINTYRE, JM

PINKUS, GS

MOLONEY, WC

FREI, E

机构：

[1] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA

[2] MAINE MED CTR, PORTLAND, ME 04102 USA

来源：

关键词：

D O I：

10.1200/JCO.1983.1.2.91

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：91 / 98

页数：8

共 51 条

[1] ARMITAGE JO, 1980, CANCER TREAT REP, V64, P649
[2] BAUER BA, AM J MED
[3] CLINICAL-PHARMACOLOGY OF METHOTREXATE
BERTINO, JR
[J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1982, 10 (04): : 401 - 411
[4] PROTECTED ENVIRONMENT PROPHYLACTIC ANTIBIOTIC PROGRAM FOR MALIGNANT-LYMPHOMA - RANDOMIZED TRIAL DURING CHEMOTHERAPY TO INDUCE REMISSION
BODEY, GP
RODRIGUEZ, V
CABANILLAS, F
FREIREICH, EJ
[J]. AMERICAN JOURNAL OF MEDICINE, 1979, 66 (01) : 74 - 81
[5] BONADONNA G, 1977, CANCER TREAT REP, V61, P1117
[6] BUNN PA, 1976, BLOOD, V47, P3
[7] FACTORS PREDICTING FOR RESPONSE AND SURVIVAL IN ADULTS WITH ADVANCED NON-HODGKINS LYMPHOMA
CABANILLAS, F
BURKE, JS
SMITH, TL
MOON, TE
BUTLER, JJ
RODRIGUEZ, V
[J]. ARCHIVES OF INTERNAL MEDICINE, 1978, 138 (03) : 413 - 418
[8] CADMAN E, 1977, CANCER TREAT REP, V61, P1109
[9] CANELLOS GP, 1979, 1978 INT S CNS COMPL, P142
[10] CARBONE PP, 1971, CANCER RES, V31, P1860